Diego Centonze Selected Research

Plastics

4/2017	Heart rate variability is differentially altered in multiple sclerosis: implications for acute, worsening and progressive disability.
5/2010	Effects of anodal transcranial direct current stimulation on chronic neuropathic pain in patients with multiple sclerosis.
4/2007	The endocannabinoid pathway in Huntington's disease: a comparison with other neurodegenerative diseases.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Diego Centonze Research Topics

Disease

130	Multiple Sclerosis 08/2024 - 04/2004
44	Inflammation (Inflammations) 10/2023 - 03/2009
27	Experimental Autoimmune Encephalomyelitis (Encephalomyelitis, Autoimmune Experimental) 05/2024 - 10/2007
25	Parkinson Disease (Parkinson's Disease) 01/2023 - 08/2002
22	Relapsing-Remitting Multiple Sclerosis 04/2024 - 03/2012
16	Neuroinflammatory Diseases 05/2024 - 01/2007
14	Disease Progression 04/2024 - 03/2011
13	Neurodegenerative Diseases (Neurodegenerative Disease) 04/2024 - 04/2007
9	Huntington Disease (Huntington's Disease) 04/2017 - 01/2004
8	Alzheimer Disease (Alzheimer's Disease) 03/2023 - 04/2007
7	COVID-19 10/2023 - 01/2021
6	Infections 01/2023 - 01/2018
6	Fatigue 08/2022 - 07/2011
6	Pain (Aches) 01/2021 - 12/2009
6	Demyelinating Diseases (Demyelinating Disease) 01/2019 - 03/2009
6	Dyskinesias (Dyskinesia) 10/2007 - 05/2003
5	Cognitive Dysfunction 03/2023 - 02/2011
5	Hypersensitivity (Allergy) 04/2021 - 07/2004
5	Parkinsonian Disorders (Parkinsonism) 07/2004 - 08/2002
4	Nervous System Diseases (Neurological Disorders) 01/2023 - 06/2014
4	Amyotrophic Lateral Sclerosis (Lou Gehrig's Disease) 01/2023 - 01/2007
4	Optic Neuritis (Retrobulbar Neuritis) 05/2022 - 01/2013
4	Neoplasms (Cancer) 01/2022 - 01/2017
4	Progressive Multifocal Leukoencephalopathy 01/2018 - 08/2014
4	Schizophrenia (Dementia Praecox) 03/2011 - 09/2004
4	Ischemia 07/2006 - 01/2002
3	Narcolepsy 09/2022 - 01/2018
3	Epilepsy (Aura) 01/2018 - 11/2012
3	Ischemic Stroke 10/2016 - 10/2007
3	Substance-Related Disorders (Drug Abuse) 01/2010 - 08/2004
3	Infarction (Infarctions) 07/2007 - 12/2002
3	Brain Ischemia (Cerebral Ischemia) 05/2007 - 02/2003
2	Autoimmune Diseases (Autoimmune Disease) 05/2024 - 10/2015
2	Lymphopenia (Lymphocytopenia) 03/2024 - 06/2021
2	Necrosis 11/2021 - 01/2019
2	Movement Disorders (Movement Disorder) 10/2021 - 01/2017
2	Disorders of Excessive Somnolence (Hypersomnia) 11/2020 - 01/2018
2	Anhedonia 01/2020 - 01/2018
2	Deglutition Disorders (Dysphagia) 10/2019 - 01/2019

Drug/Important Bio-Agent (IBA)

21	CytokinesIBA 01/2023 - 09/2011
20	EndocannabinoidsIBA 04/2024 - 08/2002
18	Glutamic Acid (Glutamate)FDA Link 01/2023 - 07/2004
14	Natalizumab (Tysabri)FDA Link 04/2024 - 09/2010
14	Cladribine FDA LinkGeneric 03/2024 - 11/2013
14	CannabinoidsIBA 01/2022 - 01/2007
13	Proteins (Proteins, Gene)FDA Link 03/2023 - 01/2008
10	Biomarkers (Surrogate Marker)IBA 11/2023 - 01/2008
10	Fingolimod Hydrochloride (FTY720)FDA Link 01/2022 - 03/2015
9	Levodopa (L Dopa)FDA LinkGeneric 10/2007 - 12/2002
8	TabletsIBA 02/2023 - 01/2020
8	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2018 - 03/2009
8	Cannabinoid Receptors (Cannabinoid Receptor)IBA 01/2016 - 06/2005
7	InterferonsIBA 01/2022 - 03/2012
7	Dopamine (Intropin)FDA LinkGeneric 10/2021 - 08/2002
6	ocrelizumabIBA 05/2024 - 04/2021
6	nitazoxanide (NTZ)FDA Link 09/2022 - 08/2014
6	nabiximols (Sativex)IBA 01/2022 - 10/2009
6	Dimethyl FumarateIBA 06/2021 - 08/2015
5	Retinaldehyde (Retinal)IBA 11/2023 - 01/2013
5	VaccinesIBA 10/2023 - 07/2021
5	EnzymesIBA 03/2023 - 11/2012
5	anandamide (arachidonylethanolamide)IBA 01/2020 - 08/2002
5	Dronabinol (THC)FDA LinkGeneric 01/2020 - 12/2009
5	Neuroprotective AgentsIBA 01/2018 - 02/2003
5	Interferon-betaIBA 01/2017 - 01/2014
5	Oxidopamine (6 Hydroxydopamine)IBA 04/2012 - 08/2002
4	MicroRNAs (MicroRNA)IBA 01/2023 - 01/2017
4	Interleukin-6 (Interleukin 6)IBA 01/2022 - 01/2015
4	N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA 01/2013 - 02/2003
4	gamma-Aminobutyric Acid (GABA)IBA 11/2012 - 06/2005
3	Amyloid (Amyloid Fibrils)IBA 03/2023 - 02/2011
3	D-Aspartic Acid (D Aspartate)IBA 01/2023 - 10/2008
3	Amino Acids FDA Link 01/2023 - 10/2008
3	Interleukin-2 (IL2)IBA 10/2022 - 09/2017
3	InterleukinsIBA 08/2022 - 01/2019
3	Glatiramer Acetate (Copaxone)FDA Link 01/2022 - 06/2013
3	Interferon beta-1a FDA Link 01/2021 - 07/2012
3	LipidsIBA 01/2020 - 11/2016
3	CannabidiolIBA 01/2020 - 12/2009
3	Glucose (Dextrose)FDA LinkGeneric 01/2019 - 02/2003
3	Platelet-Derived Growth FactorIBA 04/2018 - 12/2013
3	PlasticsIBA 04/2017 - 04/2007
3	CB1 Cannabinoid Receptor (CB1 Receptor)IBA 12/2014 - 03/2011
3	Succinate Dehydrogenase (Fumarate Reductase)IBA 04/2008 - 01/2004
2	Complement System Proteins (Complement)IBA 05/2024 - 11/2010
2	ofatumumab FDA Link 05/2024 - 01/2023
2	glyceryl 2-arachidonate (2-arachidonoylglycerol)IBA 04/2024 - 08/2002
2	Excitatory Amino AcidsIBA 01/2023 - 06/2003
2	Serine (L-Serine)FDA Link 01/2023 - 10/2008
2	Influenza Vaccines (Influenza Vaccine)FDA Link 11/2022 - 04/2021
2	pitolisantIBA 09/2022 - 01/2018
2	Interleukin-1beta (Interleukin 1 beta)IBA 11/2021 - 02/2015
2	ProteomeIBA 01/2021 - 07/2015
2	Cholinergic Agents (Cholinergics)IBA 11/2019 - 05/2007
2	Apomorphine FDA Link 09/2019 - 01/2019

Therapy/Procedure

28	Therapeutics 08/2024 - 07/2004
15	Transcranial Magnetic Stimulation 01/2022 - 04/2004
6	Injections 01/2022 - 07/2013
4	Transcranial Direct Current Stimulation 10/2019 - 05/2010
2	Physical Therapy Modalities (Physical Therapy Technique) 01/2021 - 12/2014